These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway. Matsushima-Nishiwaki R; Toyoda H; Takamatsu R; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Yoshimi N; Kumada T; Kozawa O Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1629-1639. PubMed ID: 28456666 [TBL] [Abstract][Full Text] [Related]
4. Direct association of heat shock protein 20 (HSPB6) with phosphoinositide 3-kinase (PI3K) in human hepatocellular carcinoma: regulation of the PI3K activity. Matsushima-Nishiwaki R; Kumada T; Nagasawa T; Suzuki M; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Toyoda H; Kozawa O PLoS One; 2013; 8(11):e78440. PubMed ID: 24223153 [TBL] [Abstract][Full Text] [Related]
5. Suppression by heat shock protein 20 of hepatocellular carcinoma cell proliferation via inhibition of the mitogen-activated protein kinases and AKT pathways. Matsushima-Nishiwaki R; Adachi S; Yoshioka T; Yasuda E; Yamagishi Y; Matsuura J; Muko M; Iwamura R; Noda T; Toyoda H; Kaneoka Y; Okano Y; Kumada T; Kozawa O J Cell Biochem; 2011 Nov; 112(11):3430-9. PubMed ID: 21769911 [TBL] [Abstract][Full Text] [Related]
6. Heat shock protein 20 (HSPB6) regulates apoptosis in human hepatocellular carcinoma cells: Direct association with Bax. Nagasawa T; Matsushima-Nishiwaki R; Toyoda H; Matsuura J; Kumada T; Kozawa O Oncol Rep; 2014 Sep; 32(3):1291-5. PubMed ID: 24969689 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-294 Promotes Cell Proliferation, Migration and Invasion in SMMC-7721 Hepatoma Carcinoma Cells by Activating the JNK/ERK Signaling Pathway. Cheng X; Chen M; Liu Z Am J Med Sci; 2020 Jun; 359(6):365-371. PubMed ID: 32498943 [TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression. Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054 [TBL] [Abstract][Full Text] [Related]
10. Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis. Jin J; Wang SJ; Cui J; Li L; Li JY; Liu FL; Sun XX; Jiang JL; Cui HY; Chen ZN Cell Oncol (Dordr); 2019 Aug; 42(4):537-554. PubMed ID: 31016558 [TBL] [Abstract][Full Text] [Related]
11. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
12. Quercetin suppresses the migration of hepatocellular carcinoma cells stimulated by hepatocyte growth factor or transforming growth factor-α: Attenuation of AKT signaling pathway. Yamada N; Matsushima-Nishiwaki R; Kozawa O Arch Biochem Biophys; 2020 Mar; 682():108296. PubMed ID: 32032576 [TBL] [Abstract][Full Text] [Related]
13. miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway. Yang F; Yin Y; Wang F; Wang Y; Zhang L; Tang Y; Sun S Hepatology; 2010 May; 51(5):1614-23. PubMed ID: 20209605 [TBL] [Abstract][Full Text] [Related]
14. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway. Matsushima-Nishiwaki R; Yamada N; Hattori Y; Hosokawa Y; Tachi J; Hori T; Kozawa O PLoS One; 2022; 17(1):e0262485. PubMed ID: 35007301 [TBL] [Abstract][Full Text] [Related]
15. GLP-1 reduces the migration of hepatocellular carcinoma cells via suppression of the stress-activated protein kinase/c-Jun N-terminal kinase pathway. Yamada N; Matsushima-Nishiwaki R; Kobayashi K; Tachi J; Kozawa O Arch Biochem Biophys; 2021 May; 703():108851. PubMed ID: 33771507 [TBL] [Abstract][Full Text] [Related]
16. Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis. Guo K; Kang NX; Li Y; Sun L; Gan L; Cui FJ; Gao MD; Liu KY BMC Cancer; 2009 Mar; 9():100. PubMed ID: 19331697 [TBL] [Abstract][Full Text] [Related]
17. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma. Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552 [TBL] [Abstract][Full Text] [Related]
18. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells. Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895 [TBL] [Abstract][Full Text] [Related]
19. Upregulation by duloxetine of the transforming growth factor-α-induced migration of hepatocellular carcinoma cells via enhancement of the c-Jun N-terminal kinase activity. Matsushima-Nishiwaki R; Kamoi S; Kozawa O Cell Biochem Funct; 2023 Oct; 41(7):814-822. PubMed ID: 37814477 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway. Geng D; Zhao W; Feng Y; Liu J Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]